• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年英格兰东南部一所初中百日咳爆发的调查及两种非细胞百日咳加强疫苗的比较

Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019.

机构信息

Immunisation and Countermeasures Division, National Infection Service, Public Health England, London, United Kingdom.

Surrey and Sussex Health Protection Team (South East), Public Health England, Surrey, United Kingdom.

出版信息

Euro Surveill. 2021 Mar;26(12). doi: 10.2807/1560-7917.ES.2021.26.12.2000244.

DOI:10.2807/1560-7917.ES.2021.26.12.2000244
PMID:33769247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7995557/
Abstract

In March 2019, a pertussis outbreak occurred in children in a junior school (7-11 years) in England who had been offered pertussis-containing booster vaccine at 40 months of age. In a case-control investigation, we assessed the extent of transmission and any difference in protection afforded to those who had previously received a booster 3- or 5-component acellular pertussis vaccine (aP). We took oral fluid specimens from the students to determine IgG antibodies against pertussis toxin (anti-PT). Parents of students attending the school were sent a questionnaire on pertussis symptoms and vaccination status was retrieved from general practitioner records for all students. Of 381 students, 134 (35.2%) were classified as pertussis cases, 133 by demonstration of significant anti-PT IgG titres and one clinically. There was no significant difference in the risk of pertussis between students receiving 3-component (33.7%) or 5-component (32.3%) aP boosters. However, pertussis infection differed significantly in school year 4, with 22.9%, 50.0%, 23.7% and 38.1% pertussis cases in years 3, 4, 5 and 6, respectively. The proportion of students with incomplete vaccinations recorded was higher than the proportion of those not covered according to the national reported coverage, possibly contributing to sustained transmission within the school.

摘要

2019 年 3 月,英格兰一所小学(7-11 岁)的儿童中爆发百日咳疫情,这些儿童在 40 个月大时接种了含百日咳成分的加强疫苗。在病例对照调查中,我们评估了传播的程度以及对先前接种过 3 剂或 5 剂无细胞百日咳疫苗(aP)的人的保护作用的差异。我们从学生中采集了口腔液样本,以确定针对百日咳毒素(anti-PT)的 IgG 抗体。我们向学生家长发送了一份关于百日咳症状的问卷,并从所有学生的全科医生记录中检索了疫苗接种状况。在 381 名学生中,有 134 名(35.2%)被归类为百日咳病例,其中 133 名通过证明有显著的 anti-PT IgG 滴度,1 名通过临床诊断。接受 3 剂(33.7%)或 5 剂(32.3%)aP 加强疫苗的学生百日咳的风险没有显著差异。然而,在 4 年级时,百日咳感染情况有显著差异,分别有 22.9%、50.0%、23.7%和 38.1%的百日咳病例发生在 3、4、5 和 6 年级。记录的未完全接种疫苗的学生比例高于未按全国报告的覆盖率覆盖的学生比例,这可能导致学校内持续传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14f/7995557/cbf175f170aa/2000244-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14f/7995557/df5565804385/2000244-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14f/7995557/cbf175f170aa/2000244-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14f/7995557/df5565804385/2000244-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a14f/7995557/cbf175f170aa/2000244-f2.jpg

相似文献

1
Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019.2019 年英格兰东南部一所初中百日咳爆发的调查及两种非细胞百日咳加强疫苗的比较
Euro Surveill. 2021 Mar;26(12). doi: 10.2807/1560-7917.ES.2021.26.12.2000244.
2
Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.婴儿期全程或无细胞百白破疫苗接种决定了 DTaP 加强疫苗接种的 IgG 亚类谱。
Vaccine. 2018 Jan 4;36(2):220-226. doi: 10.1016/j.vaccine.2017.11.066. Epub 2017 Dec 1.
3
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.婴儿期接种的三组分无细胞百日咳疫苗在生命最初6年的持续效力:意大利的经验。
Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81.
4
Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018.回顾性队列研究调查了 2017 年 12 月至 2018 年 6 月英国一所寄宿学校爆发百日咳期间的传播程度。
Euro Surveill. 2021 Jul;26(26). doi: 10.2807/1560-7917.ES.2021.26.26.1900736.
5
National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.2011-2012 年英格兰百日咳全国疫情:比较 3 组分和 5 组分无细胞疫苗与全细胞百日咳疫苗的病例对照研究。
Clin Infect Dis. 2020 Jan 2;70(2):200-207. doi: 10.1093/cid/ciz199.
6
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.荷兰4岁儿童接种不同百日咳疫苗加强针后的IgG反应:疫苗抗原含量的影响。
Vaccine. 2009 Nov 5;27(47):6530-6. doi: 10.1016/j.vaccine.2009.08.052. Epub 2009 Sep 1.
7
A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan.台湾学童百日咳全国血清流行病学调查。
Pediatr Infect Dis J. 2017 Dec;36(12):e307-e312. doi: 10.1097/INF.0000000000001711.
8
Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.在学龄前无细胞百日咳疫苗加强免疫2年后,接受过无细胞疫苗初免和全细胞疫苗初免的2岁儿童对百日咳的T细胞和B细胞反应差异。
Clin Vaccine Immunol. 2013 Sep;20(9):1388-95. doi: 10.1128/CVI.00270-13. Epub 2013 Jul 3.
9
Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.百日咳毒素 IgG 抗体亲合力在无细胞百日咳加强疫苗接种和自然感染后的差异。
Vaccine. 2012 Nov 6;30(48):6897-902. doi: 10.1016/j.vaccine.2012.09.003. Epub 2012 Sep 13.
10
A big pertussis outbreak in a primary school with high vaccination coverage in northern China: An evidence of the emerging of the disease in China.中国北方一所高疫苗接种覆盖率小学的百日咳大暴发:中国该疾病再现的证据。
Vaccine. 2018 Dec 18;36(52):7950-7955. doi: 10.1016/j.vaccine.2018.11.009. Epub 2018 Nov 9.

引用本文的文献

1
Epidemiological investigation of a pertussis outbreak among schoolchildren in Burkina Faso, 2019.2019年布基纳法索学童百日咳暴发的流行病学调查
BMC Res Notes. 2025 Feb 10;18(1):60. doi: 10.1186/s13104-025-07129-y.
2
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.终身预防百日咳的现状与未来展望:基于土耳其地区视角的叙述性综述
Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10.
3
The association between vaccine hesitancy and pertussis: a systematic review and meta-analysis.

本文引用的文献

1
Pertussis vaccines and protective immunity.百日咳疫苗和保护免疫。
Curr Opin Immunol. 2019 Aug;59:72-78. doi: 10.1016/j.coi.2019.03.006. Epub 2019 May 9.
2
National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.2011-2012 年英格兰百日咳全国疫情:比较 3 组分和 5 组分无细胞疫苗与全细胞百日咳疫苗的病例对照研究。
Clin Infect Dis. 2020 Jan 2;70(2):200-207. doi: 10.1093/cid/ciz199.
3
Pertussis (whooping cough).百日咳
疫苗犹豫与百日咳的关系:系统评价和荟萃分析。
Ital J Pediatr. 2023 Jul 13;49(1):81. doi: 10.1186/s13052-023-01495-8.
4
Comparing the pertussis antibody levels of healthy children immunized with four doses of DTap-IPV/Hib (Pentaxim) combination vaccine and DTaP vaccine in Quzhou, China.比较衢州市健康儿童接种 4 剂 DTap-IPV/Hib(沛儿)联合疫苗和 DTaP 疫苗后的百日咳抗体水平。
Front Immunol. 2023 Jan 6;13:1055677. doi: 10.3389/fimmu.2022.1055677. eCollection 2022.
5
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England.COVID-19 大流行对英格兰百日咳博德特氏菌感染的影响。
BMC Public Health. 2022 Feb 28;22(1):405. doi: 10.1186/s12889-022-12830-9.
BMJ. 2019 Feb 22;364:l401. doi: 10.1136/bmj.l401.
4
A big pertussis outbreak in a primary school with high vaccination coverage in northern China: An evidence of the emerging of the disease in China.中国北方一所高疫苗接种覆盖率小学的百日咳大暴发:中国该疾病再现的证据。
Vaccine. 2018 Dec 18;36(52):7950-7955. doi: 10.1016/j.vaccine.2018.11.009. Epub 2018 Nov 9.
5
Pertussis vaccines: WHO position paper - September 2015.百日咳疫苗:世界卫生组织立场文件 - 2015年9月
Wkly Epidemiol Rec. 2015 Aug 28;90(35):433-58.
6
Oral fluid testing for pertussis, England and wales, june 2007-august 2009.2007年6月至2009年8月,英格兰和威尔士针对百日咳的口腔液体检测
Emerg Infect Dis. 2014 Jun;20(6):968-75. doi: 10.3201/eid2006.131069.
7
Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review.1957 年至 2012 年英格兰和威尔士百日咳免疫接种和控制:历史回顾。
Euro Surveill. 2013 Sep 19;18(38):20587. doi: 10.2807/1560-7917.es2013.18.38.20587.
8
Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.使用改良的口腔液检测方法在英国人群中模拟原发性和学前接种无细胞百日咳疫苗后抗百日咳毒素 IgG 抗体的衰减。
J Med Microbiol. 2013 Sep;62(Pt 9):1281-1289. doi: 10.1099/jmm.0.062000-0. Epub 2013 May 30.
9
Number and order of whole cell pertussis vaccines in infancy and disease protection.婴儿期全细胞百日咳疫苗的接种次数、接种顺序与疾病预防
JAMA. 2012 Aug 1;308(5):454-6. doi: 10.1001/jama.2012.6364.
10
Rationale for pertussis booster vaccination throughout life in Europe.在欧洲终生接种百日咳加强疫苗的理由。
Lancet Infect Dis. 2011 Jul;11(7):557-70. doi: 10.1016/S1473-3099(11)70007-X. Epub 2011 May 18.